疫苗学《Vaccines》——6th Edition by (美)普洛特金

rojjer

/ A9 ]9 ^3 J! y4 z# a  [( `& e

Vaccines, 6th Edition

Apply the latest vaccination knowledge with a reference that Bill Gates calls "an indispensable guide to the enhancement of the well-being of our world." Inside Vaccines, you’ll find comprehensive and current coverage of every aspect of vaccination, from the development of each vaccine to its use in reducing disease. This medical reference book offers the expert information you need to apply the very latest techniques and information in your practice.

http://yun.baidu.com/share/link?shareid=2079860221&uk=3810996606

SECTION 1: General aspects of vaccination
2 f, x% \% h! G" c& D$ w1 A short history of vaccination 1
- u5 {% @( U$ e- x& m2 Vaccine immunology 14
3 The vaccine industry 33
4 Vaccine manufacturing 44
! e- T* Q4 R) y+ q" I5 Evolution of adjuvants across the centuries 58
. X  ^$ ]8 Z/ X- Y! \6 Vaccine additives and manufacturing residuals in the United States:
licensed vaccines 71
7 Passive immunization 80
8 General immunization practices 88
SECTION 2: Licensed vaccines
; i' s# v" Y4 Z" N: t$ ^9 Adenovirus vaccines 113
10 Anthrax vaccines 127
3 `% K+ ]1 ~6 e1 l% R# y; L) w11 Cholera vaccines 141
) S' J; T! n' y6 T' t12 Diphtheria toxoid 153
4 z& v0 U! {3 o13 Haemophilus influenzae vaccines 167
; D/ N2 B: j8 e4 X" {14 Hepatitis A vaccines 183
15 Hepatitis B vaccines 205
16 Human papillomavirus vaccines 235
& p: C6 L4 R! |; i17 Inactivated influenza vaccines 257
18 Influenza vaccine-live 294
19 Japanese encephalitis vaccines 312
& P% U' q, a5 s+ ]20 Measles vaccines 352
21 Meningococcal vaccines 388
22 Mumps vaccine 419
. N; L/ _4 B- G/ J! l! ?23 Pertussis vaccines . 447
24 Plague vaccines 493
25 Pneumococcal conjugate vaccine and pneumococcal common protein vaccines 504
( E. d) q. h3 i8 D- j: @! H26 Pneumococcal polysaccharide vaccines 542
7 G& S8 l$ F- |3 G- c. @4 x% O27 Poliovirus vaccine-inactivated . 573
28 Poliovirus vaccine-live 598
6 i( k4 `3 c+ b5 P/ j, t29 Rabies vaccines .646
8 l" U9 [, f' I, q& y; X+ H$ L$ ?/ r30 Rotavirus vaccines . 669
0 q* i) B* j7 v# o31 Rubella vaccine 688
, Z, P* {, E5 [8 u* y" q, F32 Smallpox and vaccinia 718
33 Tetanus toxoid 746
8 M9 a7 ?% y' c9 t& V/ A34 Tick-borne encephalitis virus vaccines 773
35 Tuberculosis vaccines 789
36 Typhoid fever vaccines 812
2 ^) x9 F* V6 @$ r. s# }5 o& h/ b" e37 Varicella vaccine 837
* L# t6 t) f, a$ l! n& [  d38 Yellow fever vaccine 870
39 Zoster vaccine 969
8 N0 s9 @+ R7 w& K6 X7 e. b9 D40 Combination vaccines 981
SECTION 3: Vaccines in development and new vaccine strategies
/ C1 y5 ]/ F# t3 e$ k8 b41 Biodefense and special pathogen vaccines 1008
% W, M, [4 Y- {  U1 T42 Therapeutic cancer vaccines 1018
/ d* ~3 u7 O' M/ @: Y, }$ p43 Cytomegalovirus vaccines 1032
44 Dengue vaccines 1042
45 Diarrhea caused by bacteria 1052
46 Ebola vaccine 1060
: L7 _* w6 `2 j: w47 Epstein-Barr virus vaccines 1068
# S7 S5 d' q; |7 `48 Hepatitis C vaccines 1074
49 Hepatitis E vaccines 1085
: q/ B" P. j8 G# H50 Herpes simplex virus vaccines 1090
51 Human immunodeficiency virus vaccines 1097
52 Lyme disease vaccines 1122
53 Malaria vaccines 1133
6 b+ K! |& m& z1 f54 Noninfectious disease vaccines 1138
55 Respiratory syncytial virus and parainfluenza virus vaccines 1146
56 Parasitic disease vaccines 1154
57 Staphylococcus aureus vaccines 1161
58 Streptococcus group A vaccines 1169
! x* O) Q2 N8 k& D9 b# W9 X! i59 Streptococcus group B vaccines 1176
$ L. `7 ^6 M+ |9 N3 _' ^+ ?( \5 ?60 Technologies for making new vaccines 1182
61 Alternative vaccine delivery methods 1200
62 The development of gene-based vectors for immunization 1232
; M; n8 a  y9 v% u/ D: L$ X* fSECTION 4: Vaccination of special groups
: ^. ^7 v+ E$ d) M( z% }* d63 Vaccination of immunocompromised hosts 1243
64 Vaccination of human immunodeficiency virus-infected persons 1257
65 Vaccines for international travel 1270
, ?7 [4 h+ o6 o/ t66 Vaccines for health care personnel 1290
SECTION 5: Public health and regulatory issues
) W8 l$ N: s( A3 u! C% s67 Immunization in the United States 1310
2 \  L: K1 M0 z9 G1 m5 D68 Immunization in Europe . 1334
9 E) y8 [: a6 q* n69 Immunization in the Asia-Pacific region 1353
70 Immunization in developing countries 1369
- L" l7 q' I0 B+ y71 Community immunity 1395
0 Q, X& V. {" @! o72 Economic analyses of vaccine policies 1413
73 Regulation and testing of vaccines 1427
4 z+ _) S/ ~4 r74 Regulation of vaccines in Europe 1447
75 Regulation of vaccines in developing countries 1454
/ |) A8 X8 j/ f% b76 Vaccine safety 1464
77 Legal issues . 1481
4 b5 }1 q6 i4 q; R78 Ethics 1508


3 e4 H0 E% F8 N# v

salina

非常感谢

zhpu2008

谢谢分享

zhpu2008

怎么看不到相关下载呀

rojjer

Vaccines, 6th Edition
$ c/ A: @( Z$ |, E9 u
4 _# p5 }8 ]7 o4 |5 w; J, i8 l8 ]7 @Apply the latest vaccination knowledge with a reference that Bill Gates calls "an indispensable guide to the enhancement of the well-being of our world." Inside Vaccines, you’ll find comprehensive and current coverage of every aspect of vaccination, from the development of each vaccine to its use in reducing disease. This medical reference book offers the expert information you need to apply the very latest techniques and information in your practice.

1 r9 i1 o! N9 w5 @* ~http://yun.baidu.com/share/link? ... 1&uk=3810996606
$ k( d. e6 Z- \
SECTION 1: General aspects of vaccination
1 A short history of vaccination 1
2 Vaccine immunology 14
( s! W3 N( w7 B" `9 b4 ]0 m3 The vaccine industry 33
4 \: W8 ~& N$ O% s- Q4 W4 Vaccine manufacturing 44
0 M7 Y2 ^6 \; A* V5 Evolution of adjuvants across the centuries 58
' r/ z  f. H5 _- {7 B) Q6 Vaccine additives and manufacturing residuals in the United States:
licensed vaccines 71
7 Passive immunization 80
% V. j8 [2 ?' i6 L8 General immunization practices 88
SECTION 2: Licensed vaccines
9 Adenovirus vaccines 113
9 q3 a5 V7 q3 E7 e, ~: d+ w10 Anthrax vaccines 127
* i% b9 r% ~3 n9 g. v1 a11 Cholera vaccines 141
! P/ v: P6 Q" ?2 c& T12 Diphtheria toxoid 153
13 Haemophilus influenzae vaccines 167
14 Hepatitis A vaccines 183
15 Hepatitis B vaccines 205
& F8 m2 U7 p. N3 u% i- l/ v16 Human papillomavirus vaccines 235
17 Inactivated influenza vaccines 257
18 Influenza vaccine-live 294
19 Japanese encephalitis vaccines 312
20 Measles vaccines 352
% E, k( w: r/ y7 T1 g! o% L' ~& ?' H21 Meningococcal vaccines 388
22 Mumps vaccine 419
% m5 ~3 M* {9 t( z: }0 I6 p: O23 Pertussis vaccines . 447
24 Plague vaccines 493
" y* R. x' F0 j' y7 X4 w0 R25 Pneumococcal conjugate vaccine and pneumococcal common protein vaccines 504
26 Pneumococcal polysaccharide vaccines 542
0 Z8 v& }" ~+ u27 Poliovirus vaccine-inactivated . 573
28 Poliovirus vaccine-live 598
9 R" w- T2 r1 q$ Q6 k1 u29 Rabies vaccines .646
; G3 L* _' n0 z30 Rotavirus vaccines . 669
3 K( e1 H: Z; k& f31 Rubella vaccine 688
32 Smallpox and vaccinia 718
33 Tetanus toxoid 746
34 Tick-borne encephalitis virus vaccines 773
35 Tuberculosis vaccines 789
36 Typhoid fever vaccines 812
) s* U1 U7 e$ v* X. w37 Varicella vaccine 837
38 Yellow fever vaccine 870
39 Zoster vaccine 969
8 _2 ?) ]4 s1 c% O40 Combination vaccines 981
7 O" R+ K; M  d  T. B1 ]SECTION 3: Vaccines in development and new vaccine strategies
41 Biodefense and special pathogen vaccines 1008
0 [5 r6 I: j, o# \* H1 K42 Therapeutic cancer vaccines 1018
43 Cytomegalovirus vaccines 1032
; q( C2 m3 w! f) h2 k, \' ]44 Dengue vaccines 1042
- m; A) [9 ~" {. W" [% A, ^: Q45 Diarrhea caused by bacteria 1052
46 Ebola vaccine 1060
47 Epstein-Barr virus vaccines 1068
$ j4 G9 Q; j# V1 J. M( r2 ]2 g48 Hepatitis C vaccines 1074
49 Hepatitis E vaccines 1085
50 Herpes simplex virus vaccines 1090
$ g3 Q: I1 \' g5 A/ N6 x51 Human immunodeficiency virus vaccines 1097
- E5 l1 J5 f; ^52 Lyme disease vaccines 1122
53 Malaria vaccines 1133
0 d5 ^. }7 L) R" J; p) K; e54 Noninfectious disease vaccines 1138
4 F& n& n6 M* D7 }, f8 D" Z; T55 Respiratory syncytial virus and parainfluenza virus vaccines 1146
56 Parasitic disease vaccines 1154
57 Staphylococcus aureus vaccines 1161
58 Streptococcus group A vaccines 1169
2 g/ d3 w. `2 b6 Z3 }, W+ m8 ^. v59 Streptococcus group B vaccines 1176
$ {" S6 ^- P0 n) X9 M! e60 Technologies for making new vaccines 1182
) o* B4 S" V# p, C61 Alternative vaccine delivery methods 1200
" l# h! {( r  a- @, x62 The development of gene-based vectors for immunization 1232
SECTION 4: Vaccination of special groups
- s! [5 c3 e( Z$ P" L6 ^* Z63 Vaccination of immunocompromised hosts 1243
64 Vaccination of human immunodeficiency virus-infected persons 1257
65 Vaccines for international travel 1270
66 Vaccines for health care personnel 1290
SECTION 5: Public health and regulatory issues
67 Immunization in the United States 1310
68 Immunization in Europe . 1334
69 Immunization in the Asia-Pacific region 1353
5 f% j5 B2 x: w4 w70 Immunization in developing countries 1369
! I) l& }! q4 ~71 Community immunity 1395
# _5 ?0 D( s5 F4 }8 ]2 T$ I72 Economic analyses of vaccine policies 1413
+ O/ O2 |; P# v73 Regulation and testing of vaccines 1427
74 Regulation of vaccines in Europe 1447
# [5 f/ Z4 D' Z+ y9 R3 i: d/ P75 Regulation of vaccines in developing countries 1454
  B5 ]. t4 y# o) O# _: y3 v( P76 Vaccine safety 1464
77 Legal issues . 1481
78 Ethics 1508


: u( v$ h. O3 ~

casarett

Vaccines, 6e, 2012

Hardcover: 1570 pages
Publisher: Saunders; 6 edition (October 30, 2012)
Language: English
, D& \+ c$ `5 F, a% ^ISBN-10: 1455700908
& E( D- V' }2 B+ ^Size: 52.3mb (original pdf)

  |$ q, f: w* U- L3 e2013 BMA Medical Book Awards Highly Commended in Public Health!
Apply the latest vaccination knowledge with a reference that Bill Gates calls "an indispensable guide to the enhancement of the well-being of our world." Inside Vaccines, you’ll find comprehensive and current coverage of every aspect of vaccination, from the development of each vaccine to its use in reducing disease. This medical reference book offers the expert information you need to apply the very latest techniques and information in your practice!

! {5 o$ s. I; G1 Y" Y! b# U* U. HGain a complete understanding of each disease, including clinical characteristics, microbiology, pathogenesis, diagnosis, and treatment, as well as epidemiology and public health and regulatory issues.
  i- I6 |5 O1 ?! O1 UUpdate your knowledge of both existing vaccines and vaccines currently in the research and development stage.
6 g# a0 U: S, F5 a4 D; BGet complete answers on each vaccine, including its stability, immunogenicity, efficacy, duration of immunity, adverse events, indications, contraindications, precautions, administration with other vaccines, and disease-control strategies.
Analyze the cost-benefit and cost-effectiveness of different vaccine options.
' k9 H# k8 o8 \- }0 u3 n1 uClearly visualize concepts and objective data through an abundance of tables and figures.
+ U- O' Z" _/ @4 E8 F4 u7 b" S8 XPerform seamless searches of the complete text online, access all the references, and download all the images at www.expertconsult.com.
0 I; b9 B  r$ Q) i* _$ [. wMake optimal use of the latest vaccines for pneumococcal disease, rotavirus, human papillomavirus, herpes zoster, meningococcal disease, and much more.
Stay at the forefront of new developments with completely updated chapters on malaria and HIV vaccines, a new chapter on vaccine regulations across the world, and many other revisions throughout.

7 ~/ [2 }: {, J( z) W# [% ~: RDownload link: http://pan.baidu.com/s/1i5NxwLR
Code for downloading: dv96